Tisbury Pharmaceuticals

Small fusion molecule drug to treat open angle glaucoma

placeSafed, North District, Israel calendar_todayFounded 2015 language tisburypharmaceuticals.com

Innovation

2 patent families (1 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace dormant. Cited 13 times.

YearFilings
20161
20171

Investor mix

5 investors on record; lead investors include Orbimed.

Investor typeCountShare
Venture capital360%
Other / undisclosed240%
Coming soon